Thalidomide-O-amide-C5-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology
stimulates transcription of MMP-1 in human HSC-derived TWNT-4 cells
Smiles: C[C@H]1[C@H](CCC(=O)OC)C2N=C1C=C1NC(=CC3=NC(=CC4NC5=C(C(=O)CC=25)C=4C)C(CC)=C3C)C(C=C)=C1C
InChiKey: SBHXYTNGIZCORC-ZDUSSCGKSA-N
23(5):1407-1412
Gypenoside LI Size:Contact [email protected] for quotation Thalidomide-O-amide-C5-NH2 TFA is a synthesizedGypenoside LI, a gypenoside monomer, possesses anti tumor activity. Gypenoside LI induces cell apoptosis, cell cycle and migration. Product information CAS Number: 94987 10 7 Molecular Weight: 801. 01 Formula: C42H72O14 Chemical Name: (2S,3R,4S,5S,6R) 2 {[(2R,3R,4S,5S,6R) 2 {[(1S,3aR,3bR,5aR,7R,8R,9aR,9bR,11R,11aR) 8,11 dihydroxy 1 [(2R) 2 hydroxy 6 methylhept 5 en 2 yl] 3a,3b,6,6,9a pentamethyl hexadecahydro 1H cyclopenta[a]phenanthren 7 yl]oxy} 4,5